Written by Steve Cannon for USSA News. Two older adults who received Pfizer’s RSV vaccine during a clinical trial have been diagnosed with the rare neurological disorder Guillain-Barré syndrome, according to a briefing document released by the Food and Drug Administration (FDA). The FDA has flagged the two cases of Guillain-Barré syndrome as an “important
This post was created with our nice and easy submission form. Create your post!